A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)Basking Ridge, New Jersey, United States, 07920Contact: Mark Geyer, MD    646-608-3745      Memorial Sloan Kettering Monmouth (Limited protocol activities)Middletown, New Jersey, United States, 07748Contact: Mark Geyer, MD    646-608-3745      Memorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale, New Jersey, United States, 07645Contact: Mark Geyer, MD    646-608-3745      Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities)Commack, New York, United States, 11725Contact: Mark Geyer, MD    646-608-3745      Memorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison, New York, United States, 10604Contact: Mark Geyer, MD    646-608-3745      Memorial Sloan Kettering Cancer Center (All protocol activites)New York, New York, United States, 10065Contact: Mark Geyer, MD    646-608-3745      Memorial Sloan Kettering Nassau (Limited Protocol Activites)Rockville Centre, New York, United States, 11553Contact: Mark Geyer, MD    646-608-3745      

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 3, 2023Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments